ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#1861
ANI Pharmaceuticals, Inc.
73.900
0
-2.95%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
-2.95%
月次変化
-7.56%
6か月変化
-21.91%
1年の変化
-21.91%
以前の終値
76.145
0
Open
73.900
0
Bid
Ask
Low
73.900
0
High
73.900
0
ボリューム
73
マーケット
株
ヘルスケア
ANIP
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
12.35 M
17.26 M
17.49 M
21.07 M
21.76 M
22.41 M
—
Valuation ratios
Enterprise value
1.07 B
2.29 B
2.05 B
3.4 B
3.47 B
3.25 B
17.4 B
Price to earnings ratio
-15.45
-13.55
-13.13
67.28
-53.15
23.78
-100.58
Price to sales ratio
1.67
2.69
2.06
2.14
1.74
—
—
Price to cash flow ratio
22.76
174.72
20.86
8.75
16.68
9.05
45.65
Price to book ratio
1.78
1.74
2.08
2.4
2.65
3.1
5.7
Enterprise value to EBITDA ratio
23.96
68.32
21.63
19.62
7.92
—
—
Profitability ratios
Return on assets %
-0.05
-0.06
-0.06
0.02
-0.01
0.05
0.06
Return on equity %
-0.12
-0.13
-0.15
0.04
-0.05
0.14
0.16
Return on invested capital %
-13.62
-22.39
-16.37
26.94
0.23
33.73
34
Gross margin %
58.19
53.45
56.13
62.71
59.27
61.36
246.07
Operating margin %
-7.68
-18.41
-11.15
9.65
0.1
12.58
49.84
EBITDA margin %
21.41
15.49
30.02
35.55
71.25
30
140.79
Net margin %
-10.82
-19.71
-15.14
3.86
-3.01
8.87
34.81
Liquidity ratios
Quick ratio
1.39
2.74
2.4
2.81
2.02
2.19
8.17
Current ratio
2.17
3.68
3.46
3.57
2.72
2.71
10.49
Inventory turnover
—
1.41
1.48
1.68
2.02
2.44
2.42
Asset turnover
0.45
0.35
0.41
0.58
0.56
0.65
0.65
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.37
0.37
0.38
0.31
0.24
0.2
0.87
Long term debt to total equity ratio
0.88
0.86
0.91
0.66
0.77
0.54
2.55
Per share metrics
Operating cash flow per share
1.28
0.26
-1.92
6.54
3.31
8.73
9
EBIT per share
-0
-1.09
-1.57
2.72
15.61
3.81
3.85
EBITDA per share
3.73
2.66
5.84
9.51
22.66
12.48
15.26
Total debt per share
—
—
—
—
—
—
—
Cash per share
0.66
7.96
2.97
12.15
7.5
13.45
44.1
Net current asset value per share
14.24
25.55
21.17
28.57
27.32
35.48
125.02
Tangible book value per share
0.3
0.94
2.08
10.75
-10.26
-0.06
-18.84
Working capital per share
7.67
18.6
15.06
20.57
17.29
22.38
77.36
Book value per share
16.36
26.51
19.29
23.79
20.9
25.47
91.84
ニュース
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View
ANI Pharma 2025年第4四半期決算:希少疾患へのシフトが44%の収益成長を牽引
ANI Pharma Q4 2025 slides: rare disease shift drives 44% revenue growth
【決算速報】Biosante Pharmaceuticals Inc、売上高は予想を上回り、利益は予想を上回る結果に
ANI Pharma earnings beat by $0.36, revenue topped estimates
ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% - ANI Pharmaceuticals (NASDAQ:ANIP)
Brightspring Health Services, BASF, Swiss Re and more set to report Friday
Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up
ANI Pharmaceuticals set to report earnings as Cortrophin drives shift